MARKETS / NASDAQ / AMTX
NASDAQ · INDUSTRIAL ORGANIC CHEMICALS · MID CAP

Aemetis, Inc. AMTX

16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$197.6M
▼ 26.2% vs FY2024
EPS · FY25
$-1.28
Dividend / sh · FY25
Payout · FY25
ROE · FY25
Net margin · FY25
-39.0%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 197.6M
Revenue, FY2025 · full 16-year series below
Revenue Net income
0.080.160.240.320.2-0.1201020132016201920222025
0.080.160.240.320.2-0.12016201920222025

The company lost 39 cents on every revenue dollar this year.

Per share
USD -1.28
Diluted EPS, FY2025
EPS
0.40.81.2-1.28201020132016201920222025
0.40.81.2-1.282016201920222025

The company pays no cash dividend.

Profitability
Return on equity, FY2025
ROE
0.250.50.751201020132016201920222025
0.250.50.7512016201920222025
Operating margin-18.8%
Net margin-39.0%
Return on assets-29.7%

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+3.6% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−8.3%
+3.6%
+3.0%
+23.7%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.07B
Shares outstanding, FY2025
0.090.07201020132016201920222025
0.000.072016201920222025
Change, 5 years+16.4%
Change, 10 years

The share count grew 16% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 259.8M
total assets, end of FY2025
Total assetsUSD 259.8M
EquityUSD -306.8M
CashUSD 4.9M
Gross debtUSD 343.0M
Net debtUSD 338.1M
Current ratio0.07×

Net debt stands at -110% of equity.

History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.2
0.3
0.2
0.3
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.2
0.2
0.2
0.1
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
0.0
0.0
−0.0
−0.0
·
Income tax $B
−0.0
−0.0
−0.1
0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
Net income $B
−0.1
−0.1
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.28
−1.91
−1.22
−3.12
−1.54
−1.74
−1.75
−1.63
−1.53
−0.79
−1.37
0.34
−1.28
−0.28
−0.18
−0.10
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Shares out B
0.07
0.05
0.04
0.04
0.03
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.18
0.13
0.09

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
60 of 64
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 4 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed